GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

LiveCare LVCE · USD

N/A · US listing · 🇺🇸 United States

Compare

0.01

—

Close of 30 Oct 2026, in USD

About LiveCare

Its shares trade under the ticker LVCE. It has been listed since 1 March 2021.

LiveCare, Inc. operates as a biotechnology firm. The company is headquartered in Park City, Utah. The company went IPO on 2021-03-01. The firm focuses on providing chronic care service and technology solutions for the diabetes epidemic through visibility-into daily health status, proactive real-time communication, personalized support and programs designed to engage diabetics in their overall wellness. Its health center is staffed by doctors, nurses, dietitians, and specialized health coaches. Its LiveCare Health is the personal care solution for seniors with diabetes. LiveCare Health offers a solution, covered by Medicare and other insurances, to help overcome the diabetes epidemic. The firm takes charge of the health of an individual, helping patients with minimizing the effects of type II diabetes. The company also works with physicians who need the Company's specialist services.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
1 Mar 2021

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • LiveCare Health offers a Medicare-covered solution for seniors with diabetes.
  • The health center is staffed by doctors, nurses, and dietitians.
  • Specialized health coaches provide personalized support for patient wellness programs.

Weaknesses

  • The company operates as a biotechnology firm with limited product diversity.
  • Park City headquarters location may restrict access to broader talent pools.
  • Reliance on specific insurance coverage limits the addressable market size.

Opportunities

  • Expanding visibility-into daily health status can improve chronic care outcomes.
  • Proactive real-time communication tools can engage more diabetics effectively.
  • Collaborating with physicians allows the company to offer specialist services.

Threats

  • The diabetes epidemic presents a complex challenge for treatment efficacy.
  • Type II diabetes management requires continuous and costly monitoring efforts.
  • Competition in the biotechnology sector may reduce market share quickly.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.